Related references
Note: Only part of the references are listed.Tumor morphology and location associate with immune cell composition in pleomorphic sarcoma
Rosanna L. Wustrack et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
A C-circle assay for detection of alternative lengthening of telomere activity in FFPE tissue
Aurora I. Idilli et al.
STAR PROTOCOLS (2021)
B cells are associated with survival and immunotherapy response in sarcoma
Florent Petitprez et al.
NATURE (2020)
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
Isidro Cortes-Ciriano et al.
NATURE GENETICS (2020)
The genomics of undifferentiated sarcoma of soft tissue: Progress, challenges and opportunities
Christopher D. Steele et al.
SEMINARS IN CANCER BIOLOGY (2020)
Rb and p53-Deficient Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma Require Skp2 for Survival
George Z. Li et al.
CANCER RESEARCH (2020)
Tumor-Derived Retinoic Acid Regulates Intratumoral Monocyte Differentiation to Promote Immune Suppression
Samir Devalaraja et al.
CELL (2020)
Vestigial-like family member 3 (VGLL3), a cofactor for TEAD transcription factors, promotes cancer cell proliferation by activating the Hippo pathway
Naoto Hori et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
The prognostic value of CINSARC in a randomised trial comparing histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001).
Sandro Pasquali et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Pan-cancer molecular analysis of the RB tumor suppressor pathway
Erik S. Knudsen et al.
COMMUNICATIONS BIOLOGY (2020)
Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis
Rita T. Lawlor et al.
BMC CANCER (2019)
Undifferentiated Sarcomas Develop through Distinct Evolutionary Pathways
Christopher D. Steele et al.
CANCER CELL (2019)
Neoantigen-directed immune escape in lung cancer evolution
Rachel Rosenthal et al.
NATURE (2019)
TelomereHunter - in silico estimation of telomere content and composition from cancer genomes
Lars Feuerbach et al.
BMC BIOINFORMATICS (2019)
Leveraging European infrastructures to access 1 million human genomes by 2022
Gary Saunders et al.
NATURE REVIEWS GENETICS (2019)
The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors
Andrew A. Davis et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Mutant p53 as a guardian of the cancer cell
Fiamma Mantovani et al.
CELL DEATH AND DIFFERENTIATION (2019)
Inflammatory leiomyosarcoma is a distinct tumor characterized by near-haploidization, few somatic mutations, and a primitive myogenic gene expression signature
Elsa Arbajian et al.
MODERN PATHOLOGY (2018)
Presence of TERT Promoter Mutations is a Secondary Event and Associates with Elongated Telomere Length in Myxoid Liposarcomas
Monica S. Ventura Ferreira et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Genome doubling shapes the evolution and prognosis of advanced cancers
Craig M. Bielski et al.
NATURE GENETICS (2018)
Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpoint Blockade in Solid Tumors
Aaron M. Goodman et al.
JAMA ONCOLOGY (2018)
Copy number signatures and mutational processes in ovarian carcinoma
Geoff Macintyre et al.
NATURE GENETICS (2018)
The ins and outs of telomere crisis in cancer
Patrick von Morgen et al.
GENOME MEDICINE (2018)
Nuclear Mechanopathology and Cancer Diagnosis
Caroline Uhler et al.
TRENDS IN CANCER (2018)
Recurrent TRIO Fusion in Nontranslocation-Related Sarcomas
Lucile Delespaul et al.
CLINICAL CANCER RESEARCH (2017)
Diagnosis and treatment of ALT tumors: is Trabectedin a new therapeutic option?
Luca Pompili et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hussein A. Tawbi et al.
LANCET ONCOLOGY (2017)
Systematic analysis of telomere length and somatic alterations in 31 cancer types
Floris P. Barthel et al.
NATURE GENETICS (2017)
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
Helen Davies et al.
NATURE MEDICINE (2017)
FANCM, BRCA1, and BLM cooperatively resolve the replication stress at the ALT telomeres
Xiaolei Pan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
PD-L1 (CD274) copy number gain, expression, and immune cell infiltration as candidate predictors for response to immune checkpoint inhibitors in soft-tissue sarcoma
Jan Budczies et al.
ONCOIMMUNOLOGY (2017)
Co-targeting PI3K, mTOR, and IGF1R with small molecule inhibitors for treating undifferentiated pleomorphic sarcoma
Caitlin D. May et al.
CANCER BIOLOGY & THERAPY (2017)
Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas
Alexander J. Lazar et al.
CELL (2017)
Putting p53 in Context
Edward R. Kastenhuber et al.
CELL (2017)
T-Cell Infiltration and Clonality Correlate With Programmed Cell Death Protein 1 and Programmed Death-Ligand 1 Expression in Patients With Soft Tissue Sarcomas
Seth M. Pollack et al.
CANCER (2017)
Pan-Cancer Analysis of Copy Number Changes in Programmed Death-Ligand 1 (PD-L1, CD274) - Associations with Gene Expression, Mutational Load, and Survival
Jan Budczies et al.
GENES CHROMOSOMES & CANCER (2016)
TERT promoter mutations and prognosis in solitary fibrous tumor
Armita Bahrami et al.
MODERN PATHOLOGY (2016)
Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer
Yusuke Inoue et al.
ONCOTARGET (2016)
TERT promoter mutations are rare in bone and soft tissue sarcomas of Japanese patients
Tsuyoshi Saito et al.
MOLECULAR AND CLINICAL ONCOLOGY (2016)
Loss of ATRX Suppresses Resolution of Telomere Cohesion to Control Recombination in ALT Cancer Cells
Mahesh Ramamoorthy et al.
CANCER CELL (2015)
Chromothripsis and Kataegis Induced by Telomere Crisis
John Maciejowski et al.
CELL (2015)
Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas
Jau-Yu Liau et al.
MODERN PATHOLOGY (2015)
Telomerase activation by genomic rearrangements in high-risk neuroblastoma
Martin Peifer et al.
NATURE (2015)
Deregulation of the Hippo pathway in soft-tissue sarcoma promotes FOXM1 expression and tumorigenesis
T. S. Karin Eisinger-Mathason et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors
Rachel Litman Flynn et al.
SCIENCE (2015)
Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma
Rita De Sanctis et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer
Michael T. Barrett et al.
ONCOTARGET (2015)
The evolving classification of soft tissue tumours - an update based on the new 2013 WHO classification
Christopher D. M. Fletcher
HISTOPATHOLOGY (2014)
TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities
Christian Koelsche et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas
Klaus G. Griewank et al.
MODERN PATHOLOGY (2014)
Estimating telomere length from whole genome sequence data
Zhihao Ding et al.
NUCLEIC ACIDS RESEARCH (2014)
Telomere Length A Review of Methods for Measurement
Alison J. Montpetit et al.
NURSING RESEARCH (2014)
Assembly of telomeric chromatin to create ALTernative endings
Roderick J. O'Sullivan et al.
TRENDS IN CELL BIOLOGY (2014)
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
Patrick J. Killela et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Franklin W. Huang et al.
SCIENCE (2013)
The Hippo pathway and human cancer
Kieran F. Harvey et al.
NATURE REVIEWS CANCER (2013)
Quantitative Image Analysis of Cellular Heterogeneity in Breast Tumors Complements Genomic Profiling
Yinyin Yuan et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes
Christopher M. Heaphy et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development
Philip J. Stephens et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
New insights in sarcoma oncogenesis: a comprehensive analysis of a large series of 160 soft tissue sarcomas with complex genomics
Laure Gibault et al.
JOURNAL OF PATHOLOGY (2011)
Constant p53 Pathway Inactivation in a Large Series of Soft Tissue Sarcomas with Complex Genetics
Gaelle Perot et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
YAP1 and VGLL3, Encoding Two Cofactors of TEAD Transcription Factors, Are Amplified and Overexpressed in a Subset of Soft Tissue Sarcomas
Zofia Helias-Rodzewicz et al.
GENES CHROMOSOMES & CANCER (2010)
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients
Julien Fourcade et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
A Review of Trabectedin (ET-743): A Unique Mechanism of Action
Maurizio D'Incalci et al.
MOLECULAR CANCER THERAPEUTICS (2010)
A comprehensive catalogue of somatic mutations from a human cancer genome
Erin D. Pleasance et al.
NATURE (2010)
Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity
Frederic Chibon et al.
NATURE MEDICINE (2010)
DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity
Jeremy D. Henson et al.
NATURE BIOTECHNOLOGY (2009)
The three Es of cancer immunoediting
GP Dunn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Frequent loss of 9p21 (p16INK4A) and other genomic imbalances in human malignant fibrous histiocytoma
A Simons et al.
CANCER GENETICS AND CYTOGENETICS (2000)
Share Paper
